Want to see BNTGY full AI Analyst Report?
Top Page
Brenntag AG
(OTC:BNTGY)
Select Model
Select Model
Rating:63Neutral
Price Target:
$15.00
▲(11.61% Upside)
Action:Reiterated
Date:08/18/26
The score is driven primarily by middling financial performance (profitability/ROE below prior peaks, rising leverage, and weakening free-cash-flow trend) balanced by a constructive technical backdrop and a net-positive earnings call emphasizing margin progress and cost-savings execution. Valuation is a mild headwind with a higher P/E that is only partly offset by the dividend yield.
Positive Factors
Diversified chemical distribution platform
The broad product portfolio, global distribution infrastructure and value-added services create customer utility beyond simple resale. This supports recurring relationships, supplier access and resilience across industrial and specialty end markets.
Negative Factors
Compressed profitability
Lower profitability and returns show that Brenntag’s earnings power remains below prior peaks. Thin net margins leave less room to absorb pricing pressure, weaker volumes, higher operating costs or unfavorable product mix changes.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified chemical distribution platform
The broad product portfolio, global distribution infrastructure and value-added services create customer utility beyond simple resale. This supports recurring relationships, supplier access and resilience across industrial and specialty end markets.
Read all positive factors
Brenntag AG (BNTGY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$10.28B
Dividend Yield3.13%
Average Volume (3M)3.47K
Price to Earnings (P/E)24.0
Beta (1Y)0.60
Revenue Growth1.59%
EPS Growth-6.67%
CountryUS
Employees17,339
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)0.50
Shares Outstanding721,926,800
10 Day Avg. Volume0
30 Day Avg. Volume3,474
Financial Highlights & Ratios
PEG Ratio-0.53
Price to Book (P/B)1.65
Price to Sales (P/S)0.49
P/FCF Ratio11.00
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.95
Revenue Forecast (FY)$17.97B
Brenntag AG Business Overview & Revenue Model
Company Description
Brenntag SE functions as a major global distributor, procuring and supplying a comprehensive range of industrial and specialty chemicals, as well as essential ingredients. Its extensive operations span across Europe, the Middle East, Africa, the A...
How the Company Makes Money
Brenntag primarily makes money by distributing chemicals and ingredients: it buys products from manufacturers, then sells them to customers at a markup that reflects sourcing, service, and logistics value. Key revenue streams include (1) product s...
Brenntag AG Earnings Call Summary
Earnings Call Date:Aug 12, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 11, 2026
Earnings Call Sentiment Positive
The call presented a net-positive operational and financial picture: double-digit sales growth, margin expansion, improved EBITDA conversion and clear progress on structural cost savings and commercial initiatives. These positives were tempered by a large but described-as-temporary working capital build driven by price effects, elevated personnel costs due to bonus provisions (~EUR 40m), flat volumes in some FY-critical businesses (notably Nutrition), and continued external uncertainty (geopolitics, competitor dynamics). Management expects the working capital peak to unwind into Q3 and reiterated delivery of cost-savings targets, while taking a conservative stance on H2 gross profit assumptions.Positive Updates
Strong Sales Growth
Total sales increased by about 11% year-over-year in Q2, with particularly strong performance in specialty segments (Material Science called out as a top performer).
Negative Updates
Large Working Capital Build (Temporary)
Outflow from working capital in Q2 amounted to EUR 353 million driven mainly by price effects (inventory value increased ~11.8%), creating a temporary peak that management expects to unwind into Q3.
Read all updates
Q2-2026 Updates
Positive
Negative
Strong Sales Growth
Total sales increased by about 11% year-over-year in Q2, with particularly strong performance in specialty segments (Material Science called out as a top performer).
Read all positive updates
Company Guidance
Management said they expect the H2 benefit from the Q2 pricing environment to unwind sequentially (moderating through Q3 and normalizing in Q4 to levels similar to prior year), while volumes remain broadly flat overall (specialties—notably Material Science—up, Nutrition flat); they flagged no significant product shortages and no backlog. Key metrics called out: Q2 working‑capital outflow of EUR 353m with inventory up ~11.8% on ~11% sales growth, working‑capital turns improved to 7.5x and the Q2 working‑capital peak should start to unwind in Q3; gross profit margin was up ~0.6 percentage points year‑on‑year and BSP EBITDA conversion rose ~3.3pp to 38.6%; personnel costs included ~EUR 40m of higher bonus provisions in Q2; cost‑saving initiatives have reached a run‑rate of EUR 41m and are expected to deliver ~EUR 150m in 2026 and EUR 200–250m in the next year.Brenntag AG Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
68
Positive
Cash Flow
56
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.29B | 14.57B | 16.24B | 16.82B | 19.43B | 14.38B |
| Gross Profit | 2.94B | 1.88B | 4.03B | 4.02B | 4.32B | 3.38B |
| EBITDA | 1.35B | 1.11B | 1.33B | 1.51B | 1.70B | 1.03B |
| Net Income | 368.88M | 254.16M | 536.20M | 714.90M | 886.80M | 448.30M |
Balance Sheet | ||||||
| Total Assets | 11.67B | 10.83B | 11.67B | 10.34B | 11.37B | 10.20B |
| Cash, Cash Equivalents and Short-Term Investments | 508.79M | 797.56M | 763.30M | 576.90M | 1.05B | 705.00M |
| Total Debt | 3.61B | 3.26B | 3.38B | 2.40B | 2.93B | 2.66B |
| Total Liabilities | 7.20B | 6.49B | 6.91B | 5.98B | 6.57B | 6.20B |
| Stockholders Equity | 4.43B | 4.31B | 4.73B | 4.30B | 4.75B | 3.91B |
Cash Flow | ||||||
| Free Cash Flow | 550.09M | 647.11M | 564.40M | 1.34B | 689.50M | 189.30M |
| Operating Cash Flow | 853.87M | 928.55M | 906.60M | 1.66B | 956.70M | 388.60M |
| Investing Cash Flow | -452.97M | -394.01M | -749.00M | -558.30M | -401.40M | -608.50M |
| Financing Cash Flow | -430.30M | -469.80M | 23.00M | -1.55B | -225.80M | 174.10M |
Brenntag AG Technical Analysis
Positive
13.44
Price Trends
13.40
Positive
13.48
Positive
12.51
Positive
Market Momentum
0.22
Positive
55.34
Neutral
33.68
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BNTGY, the sentiment is Positive. The current price of 13.44 is below the 20-day moving average (MA) of 14.21, above the 50-day MA of 13.40, and above the 200-day MA of 12.51, indicating a bullish trend. The MACD of 0.22 indicates Positive momentum. The RSI at 55.34 is Neutral, neither overbought nor oversold. The STOCH value of 33.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BNTGY.
Brenntag AG Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $8.44B | 19.14 | 7.42% | 4.91% | -4.30% | -46.24% | |
64 Neutral | $9.64B | -17.24 | -10.34% | ― | -1.57% | -183.83% | |
63 Neutral | $10.28B | 24.00 | 8.30% | 3.29% | 1.59% | -6.67% | |
62 Neutral | $25.00B | 16.19 | 30.22% | 2.45% | 1.47% | 23.56% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | $15.84B | 298.44 | 2.26% | 1.41% | 18.32% | ― | |
53 Neutral | $10.08B | -8.20 | -13.93% | 2.87% | -3.95% | -1725.20% |
* Basic Materials Sector Average
BNTGY
Brenntag AG
14.12
1.45
11.42%
ALB
Albemarle
143.25
63.00
78.50%
EMN
Eastman Chemical
74.09
7.95
12.01%
PPG
PPG Industries
113.63
2.27
2.04%
WLK
Westlake Corporation
78.93
-9.90
-11.14%
AVTR
Avantor
14.46
1.19
8.97%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.